Get the Stockscreener App
0.00
100.00%
-2.05
Leap Therapeutics Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Leap Therapeutics Inc is a biopharmaceutical company developing novel biomarker-targeted antibody therapies designed to treat patients with cancer by inhibiting fundamental tumor-promoting pathways, targeting cancer-specific cell surface molecules, and harnessing the immune system to attack cancer cells. The company's key clinical-stage drug candidate is sirexatamab (DKN-01), which targets Dickkopf-related protein 1 (DKK1) and is being studied in a clinical trial in patients with colorectal cancer. In addition, it also has a preclinical program to develop a proprietary monoclonal antibody, called FL-501 which works by inhibiting the GDF-15 protein.
See More
Previous Close:
$2.05
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$116.14M
Revenue:
$1.50M
Net Income/Loss:
$-64.59M
P/E Ratio:
0.00
EPS:
-1.67
Net Cash Flow:
$-55.17M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$3.58
Leap Therapeutics Inc Stock (LPTX) Company Profile
Name
Leap Therapeutics Inc
Sector
Industry
Phone
617 252 4343
Address
47 THORNDIKE STREET, CAMBRIDGE, MA
Compare LPTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LPTX
Leap Therapeutics Inc
|
0.00 | 116.14M | 1.50M | -64.59M | -55.17M | -1.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.48 | 116.04B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
718.36 | 75.97B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
458.12 | 61.48B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
901.17 | 56.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
204.00 | 43.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
Leap Therapeutics Inc Stock (LPTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-29-25 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jan-29-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jun-28-24 | Initiated | Rodman & Renshaw | Buy |
| Oct-04-21 | Initiated | Mizuho | Buy |
| Jun-04-21 | Resumed | Robert W. Baird | Outperform |
| Jun-29-20 | Initiated | Piper Sandler | Overweight |
| Feb-11-20 | Initiated | Robert W. Baird | Outperform |
| Nov-15-19 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Sep-13-19 | Resumed | Raymond James | Outperform |
| Mar-07-17 | Initiated | Ladenburg Thalmann | Buy |
View All
Leap Therapeutics Inc Stock (LPTX) Latest News
Can Leap Therapeutics Inc. (5MC) stock withstand sector downturnsTreasury Yields & Fast Entry Momentum Trade Alerts - Newser
Can Leap Therapeutics Inc. (5MC) stock attract analyst upgradesShort Setup & Real-Time Volume Triggers - Newser
Is Leap Therapeutics Inc. stock attractive for ETFsJuly 2025 Snapshot & Entry and Exit Point Strategies - Newser
How Leap Therapeutics Inc. (5MC) stock performs during market turbulenceJuly 2025 Sentiment & Weekly Market Pulse Alerts - Newser
Is Leap Therapeutics Inc. (5MC) stock undervalued historically2025 Investor Takeaways & Target Return Focused Picks - Newser
Will Leap Therapeutics Inc. (5MC) stock benefit from sector leadershipQuarterly Trade Review & Technical Pattern Based Buy Signals - Newser
Why Leap Therapeutics Inc. (5MC) stock could be next leaderTrade Risk Assessment & Accurate Technical Buy Alerts - Newser
Is Leap Therapeutics Inc. (5MC) stock a buy during volatile markets - Newser
Why ETFs are accumulating Leap Therapeutics Inc. (5MC) stockQuarterly Trade Report & Comprehensive Market Scan Insights - Newser
Promising Manufacturing Stocks To Watch TodayNovember 14th - MarketBeat
Stop Loss: Is Leap Therapeutics Inc. stock near bottom after declineWeekly Profit Recap & Fast Moving Trade Plans - moha.gov.vn
Manufacturing Stocks To Add to Your WatchlistNovember 13th - MarketBeat
CYPH: Cypherpunk Technologies Inc.Full Company Report - Zacks Investment Research
Small Cap Stocks To Keep An Eye OnNovember 18th - MarketBeat
[Form 4] LEAP THERAPEUTICS, INC. Insider Trading Activity - Stock Titan
[Form 3] LEAP THERAPEUTICS, INC. Initial Statement of Beneficial Ownership - Stock Titan
Will Leap Therapeutics Inc. (5MC) stock see valuation expansionQuarterly Earnings Report & Consistent Profit Trading Strategies - newser.com
Cypherpunk Technologies modifies warrant agreement with Winklevoss Capital By Investing.com - Investing.com Australia
What analyst consensus implies for Leap Therapeutics Inc. (5MC) stockJuly 2025 Decliners & Target Return Focused Picks - newser.com
Cypherpunk Technologies modifies warrant agreement with Winklevoss Capital - Investing.com India
Cypherpunk Technologies Modifies Warrant Agreement with Winklevoss - TipRanks
Purcell & Lefkowitz LLP Announces Shareholder Investigation of Cypherpunk Technologies Inc. (NASDAQ: CYPH) - marketscreener.com
Why Leap Therapeutics Inc. (5MC) stock remains stableMarket Volume Summary & Real-Time Buy Zone Alerts - newser.com
Is Leap Therapeutics Inc. (5MC) stock a top dividend aristocrat candidateEarnings Risk Report & High Return Stock Watch Alerts - newser.com
What downside risks could hit Leap Therapeutics Inc. (5MC) stockOil Prices & Target Return Focused Stock Picks - newser.com
Can swing trading help recover from Leap Therapeutics Inc. losses - newser.com
Why Leap Therapeutics Inc. stock is popular among millennialsJuly 2025 Trade Ideas & Smart Swing Trading Techniques - newser.com
Cypherpunk (CYPH) Stock: Doubles Down on Zcash With $18M Purchase as Privacy Coin Surges 140% - parameter.io
Leap Therapeutics, Inc.Cypherpunk Purchases Additional $18 Million of ZEC, Bringing Total Network Percentage to 1.43% - MarketScreener
Identifying reversal signals in Leap Therapeutics Inc.Portfolio Risk Summary & Fast Entry Momentum Alerts - newser.com
What RSI levels show for Leap Therapeutics Inc. (5MC) stockMarket Sentiment Review & Risk Controlled Daily Trade Plans - newser.com
Will Leap Therapeutics Inc. (5MC) stock beat Nasdaq index returnsWeekly Trend Report & Risk Adjusted Swing Trade Ideas - newser.com
CYPH Stock Price and Chart — NASDAQ:CYPH - TradingView
How Leap Therapeutics Inc. (5MC) stock performs in easing cyclesPortfolio Value Report & Free Safe Entry Trade Signal Reports - newser.com
Leap Therapeutics Inc Stock (LPTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.44%
0.91%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):